Active pharmaceutical ingredients have become a key component of each medicinal product, as part of the dynamic nature of the pharmaceutical sector. In a drug product, APIs are biological active substances. Various processes, such as chemical synthesis, fermentation, replication DNA and so on, are used to produce it. This blog is devoted to exploring the main aspects of API, from manufacturing processes to significant API manufacturing companies, and it contains an essential Chemxpert database that provides a new dimension in understanding and navigating this environment.
A wide range of complex chemical and biological processes are involved in the manufacture of API. Multistep processes using a variety of high technology processing technologies are required for the synthesis of APIs made from natural materials. The global market for active pharmaceutical ingredients is estimated at USD 206.13 billion in 2024, and is expected to reach USD 304.46 billion by 2029, growing at a compound annual growth rate of 6.72% over the forecast period of 2024 to 2029. (Courtesy: Mordor Intelligence)
Companies dedicated to the production of active ingredients are flourishing in the medicinal products market. A few examples of leading names in API manufacturing include Midas Pharma, TAPI, Sun Pharma, Dr. Reddy's Laboratories, Lonza, Livnoz Pharma, and Lupin Pharma. Comprehensive information on these companies, their specificities and contributions to the industry can be found in the Chemxpert database.
The Chemxpert database makes it easy to navigate a complex web of pharmaceutical, it has been recognized as one of the top API pharma database company in India. Chemxpert provides comprehensive global buyers-suppliers information with their contacts covering all chemicals & APIs. Ibuprofen, diphenhydramine, omeprazole, loratadine, and acetaminophen are some of the APIs listed in the Chemxpert database.
The APIs represent the biologically active components that make medicines effective and are a key component of pharmaceutical formulations. It is the main ingredient derived from raw materials with a specified strength and chemical content. In the Asia Pacific region, India is considered to be 3rd biggest producer of active ingredients API. India produces around 500 different APIs, contributing 57% to the WHO's Pre Qualified List. (Coutresy: IBEF) In 2020, the Indian API industry was worth INR 798 billion, which is expected to rise to INR 1,307 billion by 2026 at a compound annual growth rate of 8.47%. (Coutresy: Global Market Esstimates)
In accordance with the kind of medication being made, fermentation or chemical synthesis are used in the manufacturing of APIs. Choosing a compound structure, making a large amount of API, and assessing the compound for safety and quality control are the steps in the procedure.
There are many API manufacturers in India, which is known for its expertise in the pharmaceutical sector. Teva Active Pharmaceutical Ingredients, Mint Life Sciences Pvt. Ltd., Prudence Pharmachem, Mehta API Private Limited and others are API manufacturers in India.
The Chemxpert Database spotlights manufacturers, giving an overall overview of their capabilities, product portfolios and worldwide scope. For those who are walking the wide path of API production in India, it serves as a guiding light.
API pharmaceutical companies are developing, manufacturing and selling the APIs. They're procuring raw materials to produce this active substance. The API is then sent to the pharmaceutical producers that are using it for making medicines. Teva API India Limited, Pfizer Ltd, and IPCA Laboratories Limited are among the major API pharmaceutical companies.
The Chemxpert database provides a comprehensive overview of these companies' R&D initiatives, product pipelines and market positions. For those interested in working with or investing in API pharmaceutical companies, this information is of great importance.
In conclusion, the world of active pharmaceutical ingredients is complex and multifaceted; with Chemxpert database serving as a reference point for knowledge. The Chemxpert database emerges as an indispensable tool, providing insights that enable informed decisions to be made in the ever evolving landscape of the pharmaceuticals industry, when we travel through areas like API production, pharmaceutical companies and manufacturing processes.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!